HK1027568A1 - Cyanoguanidines as cell proliferation inhibitors - Google Patents

Cyanoguanidines as cell proliferation inhibitors

Info

Publication number
HK1027568A1
HK1027568A1 HK00106694A HK00106694A HK1027568A1 HK 1027568 A1 HK1027568 A1 HK 1027568A1 HK 00106694 A HK00106694 A HK 00106694A HK 00106694 A HK00106694 A HK 00106694A HK 1027568 A1 HK1027568 A1 HK 1027568A1
Authority
HK
Hong Kong
Prior art keywords
stands
cyanoguanidines
alkoxycarbonyl
carboxy
alkoxy
Prior art date
Application number
HK00106694A
Other languages
English (en)
Inventor
Charlotte Schou Hunneche
Erik Rytter Ottosen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of HK1027568A1 publication Critical patent/HK1027568A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK00106694A 1997-05-29 2000-10-23 Cyanoguanidines as cell proliferation inhibitors HK1027568A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711123.1A GB9711123D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines
PCT/DK1998/000193 WO1998054141A1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Publications (1)

Publication Number Publication Date
HK1027568A1 true HK1027568A1 (en) 2001-01-19

Family

ID=10813253

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106694A HK1027568A1 (en) 1997-05-29 2000-10-23 Cyanoguanidines as cell proliferation inhibitors

Country Status (21)

Country Link
US (2) US6346520B1 (xx)
EP (1) EP0984936B1 (xx)
JP (1) JP4349476B2 (xx)
KR (1) KR100549631B1 (xx)
CN (1) CN1121389C (xx)
AT (1) ATE248819T1 (xx)
AU (1) AU733000B2 (xx)
CA (1) CA2292775C (xx)
CZ (1) CZ293275B6 (xx)
DE (1) DE69817810T2 (xx)
DK (1) DK0984936T3 (xx)
ES (1) ES2206931T3 (xx)
GB (1) GB9711123D0 (xx)
HK (1) HK1027568A1 (xx)
HU (1) HUP0003823A3 (xx)
NZ (1) NZ501266A (xx)
PL (1) PL190249B1 (xx)
PT (1) PT984936E (xx)
RO (1) RO119880B1 (xx)
RU (1) RU2194697C2 (xx)
WO (1) WO1998054141A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061561A1 (en) 1999-04-09 2000-10-19 Shionogi Bioresearch Corp. Cyanoguanidine compounds
AU1494702A (en) 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
MXPA03010669A (es) * 2001-05-24 2004-07-01 Leo Pharma As Nuevos compuestos de cianoguanidina de piridilo.
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
CA2594508C (en) 2004-12-22 2013-10-01 Leo Pharma A/S Cyanoguanidine compounds
US8173677B2 (en) 2007-09-26 2012-05-08 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
US8211912B2 (en) 2007-09-26 2012-07-03 Gemin X Pharmaceuticals Canada Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl tranferase inhibitor
WO2010088842A1 (zh) * 2009-02-06 2010-08-12 天津和美生物技术有限公司 含有吡啶基氰基胍的药物组合物及其制备和应用
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
US8859594B2 (en) 2010-10-26 2014-10-14 Tianjin Hemay Bio-Tech Co., Ltd. Polymorphs of N-(6-(4-chlorophenoxy)hexyl)-N′-cyano-N″-(4-pyridyl)guanidine, and preparation thereof and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
GB9711125D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
AU1494702A (en) * 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs

Also Published As

Publication number Publication date
KR20010013164A (ko) 2001-02-26
ATE248819T1 (de) 2003-09-15
CA2292775A1 (en) 1998-12-03
CZ293275B6 (cs) 2004-03-17
NZ501266A (en) 2001-09-28
WO1998054141A1 (en) 1998-12-03
CA2292775C (en) 2009-10-13
KR100549631B1 (ko) 2006-02-08
PT984936E (pt) 2004-02-27
CZ9904240A3 (cs) 2001-01-17
RO119880B1 (ro) 2005-05-30
HUP0003823A2 (en) 2001-03-28
GB9711123D0 (en) 1997-07-23
PL190249B1 (pl) 2005-11-30
AU733000B2 (en) 2001-05-03
EP0984936B1 (en) 2003-09-03
DE69817810T2 (de) 2004-07-01
CN1258277A (zh) 2000-06-28
DE69817810D1 (de) 2003-10-09
DK0984936T3 (da) 2004-01-05
PL337059A1 (en) 2000-07-31
HUP0003823A3 (en) 2001-09-28
RU2194697C2 (ru) 2002-12-20
US6646129B2 (en) 2003-11-11
AU7638398A (en) 1998-12-30
EP0984936A1 (en) 2000-03-15
US6346520B1 (en) 2002-02-12
JP2001526692A (ja) 2001-12-18
CN1121389C (zh) 2003-09-17
JP4349476B2 (ja) 2009-10-21
ES2206931T3 (es) 2004-05-16
US20020107400A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
DK0984938T3 (da) Cyanoguanidiner som celleproliferationsinhibitorer
HK1080470A1 (en) Heterocyclic compounds
IL166271A0 (en) Pyrrolidinedione substituted piperidine phthalazone derivatives and pharmaceutical compositions containing the same
EP1248612A4 (en) NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS
MA28279A1 (fr) Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2
NZ547615A (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
DE69928697D1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
HK1053463A1 (en) Aminobenzophenones as inhibitors of il-1B and TNF-a.
DE60226469D1 (de) Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
DE69719350D1 (de) 2-pyrimidinamin derivaten und verfahrens zu deren herstellung
NO20066055L (no) Pyridinderivater
HK1027568A1 (en) Cyanoguanidines as cell proliferation inhibitors
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
BG103867A (en) Cyanoguanidines as cell proliferation inhibitors
BRPI0407841A (pt) inibidores heterocìclicos de quinase
WO2002014281A8 (en) Pyridine derivatives as inhibitors of p38
TW200628153A (en) Novel compounds
NO20055749L (no) Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
GB0308201D0 (en) Novel compounds
MXPA03004023A (es) Compuestos quimicos.
DE60100539D1 (en) Tosylprolin-derivate als thymidylat-synthase inhibitoren
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
MXPA05006530A (es) Derivados de 1-n-fenilamino-1h-imidazola como inhibidores aromatasa.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180514